CYCN icon

Cyclerion Therapeutics
CYCN

Overview Fund Trends Analyst Outlook Journalist POV

77 hedge funds and large institutions have $41.8M invested in Cyclerion Therapeutics in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less funds holding

Funds holding: →

33% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 24

82% less capital invested

Capital invested by funds: $237M → $41.8M (-$195M)

Holders
77
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.81M
2
+$1.54M
3
+$531K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$443K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$412K

Top Sellers

1
-$27M
2
-$24.7M
3
-$10.7M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.84M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$2.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
76
–
77
–
78
–
79
–
80
–
81
–
82
–
83
–
84
–
85
–
86
–
87
–
88
–
89
–
90
–
91
–
92
–
93
–
1 2 3
4